Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 1Phase 1 1

Status

Completed 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 1425Carcinoma, Renal Cell 586Urinary Bladder Neoplasms 368Kidney Neoplasms 257Carcinoma, Transitional Cell 190Neoplasm Metastasis 163Neoplasms 123Melanoma 83Breast Neoplasms 80Carcinoma, Non-Small-Cell Lung 77Testicular Neoplasms 67Ovarian Neoplasms 62Sarcoma 55Urethral Neoplasms 51Non-Muscle Invasive Bladder Neoplasms 50Wilms Tumor 49Lung Neoplasms 45Colorectal Neoplasms 43Neuroblastoma 39Uterine Cervical Neoplasms 38Penile Neoplasms 37Pancreatic Neoplasms 37Urologic Neoplasms 34Recurrence 32Lymphoma, Non-Hodgkin 32Ureteral Neoplasms 28Osteosarcoma 28Testicular Germ Cell Tumor 26Head and Neck Neoplasms 26Clear-cell metastatic renal cell carcinoma 26

Interventions

bintrafusp alfa protein, human 1Triamcinolone Acetonide 1TH 302 1Injections, Intramuscular 1ALT-803 1AGN 194204 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Castration Resistant Prostate Cancer × Genitourinary × Clear all
NCT06836726 2026-01-28

EVO

University Health Network, Toronto

Phase 2 Not yet recruiting
35 enrolled
Genitourinary

Castration Resistant Prostate Cancer

NCT07161778 2025-09-09

TRICREST

Barts & The London NHS Trust

Phase 2 Completed
55 enrolled
Genitourinary

Castration Resistant Prostate Cancer

NCT05445882 2024-04-02

N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Withdrawn
Genitourinary

Castration Resistant Prostate Cancer

NCT01540071 2021-05-14

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Io Therapeutics

Phase 2 Completed
38 enrolled 11 charts
Genitourinary

Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡